China IP Forum

left Nav

The 3rd China International Pharma, Biotech & Chemical Intellectual Property Forum Attracts Worldwide Attention To China Medical City, Taizhou

The Tri-State Chinese-American Chemical Society (CACS), together with the American Chemical Society (ACS) and the China Intellectual Property Society (CIPS), the Committee of Pharmaceutical Intellectual Property Rights Research of Chinese Pharmaceutical Association, and the Intellectual Property Office of Jiangsu Province, successfully held the 3rd International Pharma, Biotech & Chemical Intellectual Property Forum in China Medical City, Taizhou on May 24-27, 2012. The 3rd China IP Forum attracted an international audience of over 300. The organizing committee of the 3rd China IP Forum was co-chaired by Marinda Li Wu, President-Elect of American Chemical Society, and John D. Conway, Global Head of Innovative Healthcare Patent Support, Sanofi. The Forum received strong support from the local host, China Medical City and Taizhou Government, Jiangsu, China. The 3rd China IP Forum primarily focused on global IP protection, technology transfer and innovation commercialization. The Forum also featured a Patented Innovation Press Conference, which provided a unique platform for communication and exchange of intellectual property opportunities between Chinese and international pharmaceutical and chemical companies and institutions, as well as a day-long workshop co-organized by the 3rd China IP Forum and the Chinese Academy of Sciences.

Read All


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Globalization + IP Protection

The Forum will provide a platform for an open dialogue on Chinese and international practices in IP law, particularly patent laws as applied in the pharmaceutical and chemical industries. The Forum also aims to create business and networking opportunities among participants.





China International Intellectual Property Forum Committee Copyright © 2006-2019
All rights reserved.

Web designing by

1    2    3